Refine by
Hospitalization Data Articles & Analysis
23 news found
The multimodal study was designed to recruit 4000 participants from eight major hospitals across in Quebec, generating data that can support BioMark’s implementation within the Province of Quebec. ...
First, the in-hospital and 30-day results from the fully enrolled 800-patient US cohort of the FLASH registry will be presented at the TCT conference in Boston on September 18th. ...
When most people think of hospital data, they think of data that relates directly to the patients: demographics, diagnosis, lengths of stay, etc. ...
ByBioVigil
“It covers 100% of all patient data collected in Welsh hospitals and secondary care settings, and 85% of data collected in primary care general practice. ...
The study, “Assessment of a cellular host response test to risk-stratify suspected COVID-19 patients in the Emergency Department setting,” demonstrated that the IntelliSep test has the potential to rapidly risk-stratify patients independent of pathogen, an important finding as risk stratification may improve resource allocation in hospitals. Data from ...
In COVID-19, the body triggers an inflammatory response that produces proteins including CRP and IP-10 or CXCL-10, which are markedly elevated in hospitalized COVID-19 patients. Preliminary data LightDeck gathered in conjunction with HJF suggest that panels including CRP and IP-10 biomarkers may have utility in predicting the hospitalization risk ...
” While he is on sabbatical from Imperial College, Glocker will have a more active role in helping lead Kheiron through its next phase of deploying its technology in hospitals and analyzing patient data. The data that Kheiron ingests and analyzes over the next several months will be instrumental in answering questions that are crucial to ...
Each diagnosis and treatment are possible while replacing the module in one main device. The measured data is linked to the hospital through the app, so the patient/user can receive a prescription such as "a few milliliters of nebulizer capacity, a few minutes of LED treatment," and treatment after module replacement. ...
Thomas’ NHS Foundation Trust, a prestigious London-based hospital, presented their data at the recent Infection Prevention Society conference in Liverpool. ...
Cytovale, a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune mediated diseases, today announced the publication of a study in the peer-reviewed journal Critical Care Explorations (CCE) evaluating its IntelliSep test as a tool in the rapid diagnosis of sepsis in the hospital emergency department (ED). ...
The rapid test may aid hospital EDs in saving lives, preventing sepsis-related morbidity, and conserving resources for those who need it most. It also may assist hospitals in improving overall patient care and better meeting guidelines set by the Centers for Medicare & Medicaid Services (CMS) for timely sepsis treatment known as SEP-1. ...
“The awarded contract by Premier is a strong testimony and confirmation of the unique value CERAMENT offers hospitals, surgeons and patients. This agreement will further increase our potential reach across the US market”, said Emil Billbäck, CEO of BONESUPPORT. ...
Cytovale, a medical diagnostics company focused on providing a faster, more insightful way to diagnose fast-moving and immune mediated diseases, today announced the publication of a study in the peer-reviewed journal PLOS ONE evaluating its IntelliSep test in the rapid diagnosis of sepsis in the hospital emergency department. Data from the study, ...
This has been a year of significant progress for the Company, with a newly strengthened management team, a new Company site in Cambridge and progression into development of our cutting-edge immuno-oncology programme with Cancer Research UK and Cambridge University Hospitals that has yielded exceptional preclinical data. Hans’ experience in developing ...
To verify the safety of the hospital for patients and staff, testing was initiated. The health care workers tested positive by polymerase chain reaction (PCR), and the Center for Personalized Medicine at Children's Hospital Los Angeles performed NGS sequencing on their samples. ...
The dual-arm trial design compares HF management using daily patient vital sign data versus daily vital sign plus PA pressure data. Designed to show a definitive benefit for PA pressure-guided management, the landmark trial incorporates protocolized PA pressure therapy guidelines and guideline-directed medical therapy (GDMT) for proactive HF management. Primary ...
Cardiac Dimensions, a leader in the development of minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, presented data at the TVT2019 Structural Heart Summit showing increased mitral valve tenting is associated with an improvement in regurgitant volume with the Carillon Mitral Contour System®. ...
Under the Drug Supply Chain Security Act (DSCSA), health system pharmacies are required to receive, verify, and validate that they have complete transaction information, transaction history, transaction statement or T3 data for the products they received. To do this, hospital pharmacies must compare the physical product, including the standardized numeric ...
Ratings systems and online review sites have hospitals under the magnifying glass more than ever. Healthcare organizations must worry about their reputation with the government’s Hospital Compare data and organizations like Leapfrog. ...
The article cited a new medical report from the Agency for Healthcare Research and Quality highlighting that in 2009, skin infections resulted in 71,900 children hospital admissions. The data illustrated that skin infection hospitalization rates have increased from 4.5 cases per 10,000 children in 2000 to 9.4 cases in 2009. This remarkable ...